Experience of Boron-neutron Capture Therapy for Malignant Brain Tumours — with Special Reference to the Problems of Postoperative CT Follow-ups

  • Hiroshi Hatanaka
Part of the Acta Neurochirurgica Supplementum 42 book series (NEUROCHIRURGICA, volume 42)

Summary

Boron-neutron capture therapy (BNCT) is theoretically a highly selective treatment of infiltrating tumours, in that the tumoricidal heavy particle radiation is limited to a sphere of 10 microns around a tumour cell which is loaded with non-radioactive boron-10 atoms.

There were 73 gliomas among the 83 cases treated by boronneutron capture therapy. For grade III–IV cerebral gliomas, 5 and 10 year survival rates were an unimpressive 19 and 10% respectively. This was the result of technical problems such as unsatisfactory reactors and inadequate craniotomies for the majority of the patients. If the analysis was limited to those whose tumours had been irradiated with more than 2.5 × 1012 neutrons/cm2 (yielding more than 3,000 rem or more), the 5 and 10 year survival were almost 100 and 50%. The longest surviving glioblastoma (grade IV) patient has lived in a satisfactory manner for the past 15 years. For the cases who had been treated with borderline doses (lethal or sublethal), interpretation of the postoperative CTs was frequently intriguing. Several cases had to undergo re-opening and occasionally even another BNCT, only to find no viable tumour tissue. Death occurred in some, either due to discontinuation of supportive treatments by local physicians, or due to excessive therapies by the author directly involved in the patient’s care, both of whom had erroneously believed in recurrence. At autopsy, residual tumour cells were recognized only in the areas where the above-mentioned neutron fluence had not been delivered at the time of the treatment. Delayed cerebral necrosis was not recognized except for the cases which had purposely been given a larger neutron dose than the current regimen.

If a larger reactor like those at MIT or Brookhaven of 1951–61 series is available, and if epithermal neutron facility is constructed, any deep-seated tumours will be good targets of BNCT. Application of larger diameter craniotomy and heavy water to replace the water in the cranial space will improve the thermal neutron penetration into deeper part of the brain, and will guarantee a better survival rate.

Keywords

Glioma cerebral tumour Boron-neutron capture therapy malignant brain tumour 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Brugger RM, Less TK (1986) Intermediate energy neutron beams for neutron capture therapy — A progress report. In: Hatanaka H (ed) Neutron Capture Therapy (the Proceedings of the 2nd International Symposium on Neutron Capture Therapy, 1985, Tokyo). Nishimura & Co, Niigata, pp 110–116.Google Scholar
  2. 2.
    Hatanaka H (1986) Introduction. In: Hatanaka H (ed) Boronneutron capture therapy for tumours. Nishimura & Co, Niigata, pp 1–28.Google Scholar
  3. 3.
    Hatanaka H, Amano K, Kamano S, Fankhauser H, Hanamura T, Sano K (1978) Boron-neutron capture therapy in relation to immunotherapy. Acta Neurochir (Wien) 42: 57–72.CrossRefGoogle Scholar
  4. 4.
    Hatanaka H, Amano K, Kamano S, Tovaryš F, Machiyama N, Matsui T, Fankhauser H, Hanamura T, Nukuda T, Ito N, Sano K (1982) Boron-neutron capture therapy vs. photon beam for malignant brain tumours — 12 years experience. In: Brock M (ed) Modern neurosurgery, I. Springer, Berlin Heidelberg New York, pp 122–132.CrossRefGoogle Scholar
  5. 5.
    Hatanaka H, Kamano S, Amano K, Hojo S, Sano K, Egawa S, Yasukochi H (1986) Clinical experience of boron-neutron capture therapy for gliomas — A comparison with conventional chemo-immuno-radiotherapy. In: Hatanaka H (ed) Boron-neutron capture therapy for tumours. Nishimura & Co, Niigata, pp 349–379.Google Scholar
  6. 6.
    Hatanaka H, Sano K (1972) A revised boron-neutron capture therapy for malignant brain tumours. In: Fusek I, Kunc Z (eds) Present limits in neurosurgery. Avicenum, Czechoslovak Medical Press, Prague, pp 83–85.Google Scholar
  7. 7.
    Hatanaka H, Sano K (1973) A revised boron neutron capture therapy for malignant brain tumours. I. Experience on terminally ill patients after Cobalt-60 radiotherapy. Z Neurol 204: 309–332.PubMedGoogle Scholar
  8. 8.
    Hatanaka H, Sweet WH (1975) Slow neutron capture therapy for malignant tumours. Its history and recent developments. Biomedical Dosimetry (IAEA-SM-193/79). International Atomic Energy Agency, Vienna, pp 147–198.Google Scholar
  9. 9.
    Hatanaka H, Watanabe N (1970) Brain tumour treatment with slow neutrons (in Japanese). Geka-shinryo (= Surgical Practice) 12: 1041–1055.Google Scholar
  10. 10.
    Hatanaka H, Urano Y (1986) Eighteen autopsied cases of malignant brain tumours treated by boron-neutron capture therapy between 1968 and 1985. In: Hatanaka H (ed) Boron-neutron capture therapy for tumours. Nishimura & Co, Niigata, pp 381–416.Google Scholar
  11. 11.
    Kanda K, Kobayashi T (1986) Physics studies on neutron field and dosimetry for neutron capture therapy in Japan. In: Hatanaka H (ed) Boron-neutron capture therapy for tumours. Nishimura & Co, Niigata, pp 255–270.Google Scholar
  12. 12.
    Locher GL (1936) Biological effects and therapeutic possibilities of neutrons. Am J Roentgenol Radium Therapy 36: 1–13.Google Scholar
  13. 13.
    Matsumoto T, Aizawa O, Suetomi F, Kadotani H (1986) Dosimetry and analyses for boron-neutron capture therapy in the treatment of brain tumours. In: Hatanaka H (ed) Neutron capture therapy (the Proceedings of the 2nd International Symposium on Neutron Capture Therapy, 1985, Tokyo). Nishimura & Co, Niigata, pp 182–187.Google Scholar
  14. 14.
    Oka Y, An S (1986) Design of facilities for boron-neutron capture therapy — epithermal neutron sources. In: Hatanaka H (ed) Boron-neutron capture therapy for tumours. Nishimura & Co, Niigata, pp 243–254.Google Scholar
  15. 15.
    Wakabayashi H, Yoshii K, Sasuga N, Yanagi H (1986) Mixed dose distribution of fast neutrons and boron-neutron capture therapy for the fast neutron beam from YAYOI reactor. In: Hatanaka H (ed), Boron-neutron capture therapy for tumours. Nishimura & Co, Niigata, pp 271–282.Google Scholar
  16. 16.
    Sweet WH, Javid M (1952) The possible use of neutron capturing isotopes such as boron-10 in the treatment of neoplasms. I. Intracranial tumour. J Neurosurg 9: 200–209.PubMedCrossRefGoogle Scholar

Copyright information

© Springer-Verlag/Wien 1988

Authors and Affiliations

  • Hiroshi Hatanaka
    • 1
  1. 1.Teikyo University HospitalItabashi-Ku Tokyo 173Japan

Personalised recommendations